• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录激活因子 4/原癌基因 c-Myc 通过调节还原型叶酸载体蛋白 2 促进非小细胞肺癌的进展。

ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis.

机构信息

Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.

Key Laboratory of Immunotherapy, Xinqiao Hospital, Army Military Medical University, Chongqing, China.

出版信息

Dis Markers. 2022 Aug 22;2022:7527996. doi: 10.1155/2022/7527996. eCollection 2022.

DOI:10.1155/2022/7527996
PMID:36051358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425107/
Abstract

PURPOSE

Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) has been reported to be overexpressed in non-small-cell lung cancer (NSCLC) and to correlate with malignant proliferation. However, the mechanism of high MTHFD2 expression in NSCLC has not been clarified.

METHODS

qPCR, western blot, and immunofluorescence experiments were used to measure the expression of related mRNAs and proteins. Cell apoptosis was measured by flow cytometry and TUNEL assays. The CCK-8 assay was used to determine cell viability. Flow cytometry was used to analyze the cell cycle. ROS, HO, MDA, SOD, and NADPH/NADP were evaluated by relevant assay kits. Transfection of siRNA or vectors was used to downregulate or upregulate gene expression. Dual-luciferase reporter gene assays were used to evaluate the regulated relationship between MTHFD2 and ATF4 or MYC.

RESULTS

MTHFD2 was highly expressed in NSCLC cells. Knockdown of MTHFD2 inhibited proliferation and increased apoptosis. Furthermore, oxidative factors significantly increased, while antioxidant factors significantly decreased in NSCLC cells with MTHFD2 knockdown, indicating that MTHFD2 was involved in NSCLC progression through the redox pathway. Although MTHFD2 was downregulated with ATF4 silencing, the dual-luciferase reporter assay suggested that ATF4 did not directly mediate MTHFD2 transcription. Further studies revealed that MYC had a transcriptional effect on MTHFD2 and was also regulated by ATF4. PCR, and western blotting experiments with ATF4 knockdown and MYC overexpression as well as ATF4 overexpression and MYC knockdown proved that ATF4 stimulated MTHFD2 through MYC mediation.

CONCLUSIONS

ATF4 promoted high expression of MTHFD2 in NSCLC dependent on MYC.

摘要

目的

亚甲基四氢叶酸脱氢酶 2(MTHFD2)在非小细胞肺癌(NSCLC)中过表达,并与恶性增殖相关。然而,NSCLC 中 MTHFD2 高表达的机制尚不清楚。

方法

采用 qPCR、western blot 和免疫荧光实验检测相关 mRNAs 和蛋白的表达。通过流式细胞术和 TUNEL 检测细胞凋亡。CCK-8 法检测细胞活力。流式细胞术分析细胞周期。用相关试剂盒评估 ROS、HO、MDA、SOD 和 NADPH/NADP。通过 siRNA 或载体转染下调或上调基因表达。双荧光素酶报告基因检测评估 MTHFD2 与 ATF4 或 MYC 之间的调控关系。

结果

MTHFD2 在 NSCLC 细胞中高表达。敲低 MTHFD2 抑制增殖并增加凋亡。此外,NSCLC 细胞中 MTHFD2 敲低后氧化因子显著增加,抗氧化因子显著减少,表明 MTHFD2 通过氧化还原途径参与 NSCLC 进展。虽然 ATF4 沉默下调了 MTHFD2,但双荧光素酶报告基因检测表明 ATF4 并未直接介导 MTHFD2 转录。进一步研究表明,MYC 对 MTHFD2 具有转录效应,并且也受到 ATF4 的调控。用 ATF4 敲低和 MYC 过表达以及 ATF4 过表达和 MYC 敲低进行 PCR 和 western blot 实验证明,ATF4 通过 MYC 介导促进 NSCLC 中 MTHFD2 的高表达。

结论

ATF4 通过 MYC 促进 NSCLC 中 MTHFD2 的高表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/083c994301d4/DM2022-7527996.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/8ca64e487a60/DM2022-7527996.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/dd0b702f7995/DM2022-7527996.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/85fd2136d0ed/DM2022-7527996.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/c824ee39af56/DM2022-7527996.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/1566c3b6a1c0/DM2022-7527996.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/6d63f6b3c2e0/DM2022-7527996.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/a84594acd0d0/DM2022-7527996.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/c173d0095c27/DM2022-7527996.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/bc026ce44a87/DM2022-7527996.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/083c994301d4/DM2022-7527996.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/8ca64e487a60/DM2022-7527996.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/dd0b702f7995/DM2022-7527996.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/85fd2136d0ed/DM2022-7527996.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/c824ee39af56/DM2022-7527996.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/1566c3b6a1c0/DM2022-7527996.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/6d63f6b3c2e0/DM2022-7527996.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/a84594acd0d0/DM2022-7527996.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/c173d0095c27/DM2022-7527996.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/bc026ce44a87/DM2022-7527996.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1c/9425107/083c994301d4/DM2022-7527996.010.jpg

相似文献

1
ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis.转录激活因子 4/原癌基因 c-Myc 通过调节还原型叶酸载体蛋白 2 促进非小细胞肺癌的进展。
Dis Markers. 2022 Aug 22;2022:7527996. doi: 10.1155/2022/7527996. eCollection 2022.
2
Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.MTHFD2 的下调通过抑制周期相关基因抑制 NSCLC 的进展。
J Cell Mol Med. 2020 Jan;24(2):1568-1577. doi: 10.1111/jcmm.14844. Epub 2019 Nov 28.
3
miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia.微小RNA-92a通过调控急性髓系白血病中的亚甲基四氢叶酸脱氢酶2(MTHFD2)表达来抑制增殖并诱导凋亡。
Oncol Res. 2017 Aug 7;25(7):1069-1079. doi: 10.3727/096504016X14829256525028. Epub 2017 Jan 5.
4
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.叶酸循环酶 MTHFD2 通过上调 PD-L1 诱导癌症免疫逃逸。
Nat Commun. 2021 Mar 29;12(1):1940. doi: 10.1038/s41467-021-22173-5.
5
MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions.MTHFD2 介导的氧化还原稳态促进低氧条件下的胃癌进展。
Redox Rep. 2024 Dec;29(1):2345455. doi: 10.1080/13510002.2024.2345455. Epub 2024 May 9.
6
MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.MTHFD2 通过激活 STAT3 信号通路促进卵巢癌的生长和转移。
FEBS Open Bio. 2021 Oct;11(10):2845-2857. doi: 10.1002/2211-5463.13249. Epub 2021 Sep 18.
7
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.MTHFD2 的上调与卵巢癌的临床病理特征和不良预后相关,可能通过调节 MOB1A 信号通路。
J Ovarian Res. 2022 Feb 8;15(1):23. doi: 10.1186/s13048-022-00954-w.
8
MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.MTHFD2过表达预示肾细胞癌预后不良,并与细胞增殖以及波形蛋白调节的迁移和侵袭相关。
Cell Physiol Biochem. 2018;51(2):991-1000. doi: 10.1159/000495402. Epub 2018 Nov 22.
9
MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.微小 RNA-33a-5p 通过抑制 MTHFD2 抑制结直肠癌细胞生长。
Clin Exp Pharmacol Physiol. 2019 Oct;46(10):928-936. doi: 10.1111/1440-1681.13125. Epub 2019 Jul 22.
10
Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.环状 RNA MTHFD2 在 NSCLC 诊断、病理分期和预后中的临床意义。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9473-9479. doi: 10.26355/eurrev_202009_23032.

引用本文的文献

1
UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.UHMK1通过与MTHFD2形成正反馈回路促进前列腺癌进展。
Oncol Res. 2025 Aug 28;33(9):2331-2351. doi: 10.32604/or.2025.065119. eCollection 2025.
2
MTHFD2 in healthy and cancer cells: Canonical and non-canonical functions.健康细胞与癌细胞中的亚甲基四氢叶酸脱氢酶2:经典与非经典功能
NPJ Metab Health Dis. 2024 Mar 15;2(1):3. doi: 10.1038/s44324-024-00005-6.
3
MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type.MTHFD2标记了具有EGFR野生型的肺腺癌中的培美曲塞耐药性。

本文引用的文献

1
Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.MTHFD2 的非代谢功能激活膀胱癌中的 CDK2。
Cancer Sci. 2021 Dec;112(12):4909-4919. doi: 10.1111/cas.15159. Epub 2021 Oct 24.
2
Expression and Prognostic Value Identification of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Brain Low-Grade Glioma.亚甲基四氢叶酸脱氢酶2(MTHFD2)在脑低级别胶质瘤中的表达及预后价值鉴定
Int J Gen Med. 2021 Aug 14;14:4517-4527. doi: 10.2147/IJGM.S323858. eCollection 2021.
3
One carbon metabolism in human lung cancer.人类肺癌中的一碳代谢。
Discov Oncol. 2025 Apr 20;16(1):581. doi: 10.1007/s12672-025-02355-z.
4
Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors.放射性碘化阿那曲唑和表柔比星作为靶向实体瘤中亚甲基四氢叶酸脱氢酶2的创新放射性药物的放射学和分子分析
Pharmaceutics. 2024 May 3;16(5):616. doi: 10.3390/pharmaceutics16050616.
5
Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy.靶向癌症中的丝氨酸羟甲基转移酶(SHMTs)和亚甲基四氢叶酸脱氢酶(MTHFDs):抗肿瘤策略的诱人机遇。
Front Pharmacol. 2024 Feb 20;15:1335785. doi: 10.3389/fphar.2024.1335785. eCollection 2024.
6
Identification of microRNA editing sites in clear cell renal cell carcinoma.鉴定肾透明细胞癌中的 microRNA 编辑位点。
Sci Rep. 2023 Sep 13;13(1):15117. doi: 10.1038/s41598-023-42302-y.
Transl Lung Cancer Res. 2021 Jun;10(6):2523-2538. doi: 10.21037/tlcr-20-1039.
4
p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.p53 缺陷诱导 MTHFD2 转录,促进细胞增殖并抑制 DNA 损伤。
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28). doi: 10.1073/pnas.2019822118.
5
MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.MTHFD2 通过激活 STAT3 信号通路促进卵巢癌的生长和转移。
FEBS Open Bio. 2021 Oct;11(10):2845-2857. doi: 10.1002/2211-5463.13249. Epub 2021 Sep 18.
6
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression.应激介导的前列腺癌一碳循环重编程驱动疾病进展。
Cancer Res. 2021 Aug 1;81(15):4066-4078. doi: 10.1158/0008-5472.CAN-20-3956. Epub 2021 Jun 28.
7
MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.MTHFD2 通过调节 AKT/GSK-3β/β-catenin 信号通路促进肺腺癌的发生和转移。
J Cell Mol Med. 2021 Jul;25(14):7013-7027. doi: 10.1111/jcmm.16715. Epub 2021 Jun 13.
8
MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway.亚甲基四氢叶酸脱氢酶2(MTHFD2)通过AKT信号通路促进乳腺癌细胞增殖。
Exp Ther Med. 2021 Jul;22(1):703. doi: 10.3892/etm.2021.10135. Epub 2021 May 2.
9
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.叶酸循环酶 MTHFD2 通过上调 PD-L1 诱导癌症免疫逃逸。
Nat Commun. 2021 Mar 29;12(1):1940. doi: 10.1038/s41467-021-22173-5.
10
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.早期肺腺癌术后发生转移患者的诊疗因素识别
Theranostics. 2021 Jan 26;11(8):3661-3675. doi: 10.7150/thno.53176. eCollection 2021.